Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$36.48 - $52.22 $1.37 Million - $1.96 Million
-37,628 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$33.11 - $55.01 $1.25 Million - $2.07 Million
37,628 New
37,628 $1.64 Million
Q4 2020

Feb 12, 2021

SELL
$79.17 - $111.47 $310,346 - $436,962
-3,920 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $321,087 - $528,964
3,920 New
3,920 $405,000
Q2 2019

Aug 14, 2019

SELL
$39.92 - $53.86 $933,369 - $1.26 Million
-23,381 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $1.13 Million - $1.55 Million
23,381 New
23,381 $1.18 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.